Valuation Adjustment Mechanism law:What is the Valuation Adjustment Mechanism (VAM) and how is it regulated under current law in 2026?

Q: What is the Valuation Adjustment Mechanism (VAM) and how is it regulated under current law in 2026?

A: A Valuation Adjustment Mechanism (VAM), often called a "bet-on agreement" or "earn-out," is a contractual tool used in private equity and venture capital deals to bridge valuation gaps between investors and founders. It typically ties compensation—extra equity, cash, or share transfers—to future performance milestones such as revenue, net profit, or an IPO. Legally, VAMs are not codified as a single statute; instead, their enforceability rests on general contract principles, company law, and securities regulations. In 2026, China's Supreme People's Court's 2019 Nine Minutes and subsequent 2025 judicial interpretations continue to shape practice: VAMs between shareholders are generally valid, while those obligating the target company itself face stricter scrutiny, especially regarding capital maintenance and creditor protection. In the U.S. and EU, VAMs are governed by merger agreements under Delaware or English law, with earn-out disputes increasingly litigated over "commercially reasonable efforts" clauses. Regulatory developments in 2025-2026 include the SEC's enhanced disclosure expectations for contingent consideration in SPAC and de-SPAC transactions, and the EU's revised Prospectus Regulation requiring clearer risk disclosure for performance-linked instruments. Compliance now demands careful drafting, audited milestone metrics, and tax planning to avoid recharacterization as dividends or interest. Overall, VAMs remain lawful but highly fact-specific, so counsel should assess enforceability jurisdiction by jurisdiction before signing.

Q: How have courts interpreted VAM clauses in 2026, particularly regarding enforceability and damages?

A: In 2026, court interpretation of VAM clauses reflects a maturing but still fragmented body of law. Chinese courts, guided by the 2025 Supreme People's Court interpretation on financial investment disputes, continue to uphold VAMs between investors and controlling shareholders or actual controllers. The landmark 2019 Hua Gong case and its 2024-2025 progeny confirm that target-company buyback obligations may be valid only if the company has sufficient distributable profits and follows capital-reduction procedures; otherwise, courts may adjust the obligation to avoid harming creditors. Damages are typically calculated as the difference between the promised valuation and actual performance, but courts increasingly scrutinize whether milestones were manipulated or whether the investor contributed to underperformance. In the U.S., Delaware Chancery decisions in 2025, such as those involving earn-out disputes in life sciences M&A, emphasize that sellers must prove they satisfied objective metrics and that buyers cannot arbitrarily obstruct performance. The "implied covenant of good faith" is now a common battleground. English courts, post-2024, apply a strict contractual interpretation, enforcing clear VAM formulas unless unconscionable. Across jurisdictions, 2026 trends favor: (1) enforceability of well-drafted, transparent mechanisms; (2) rejection of punitive or penalty-like adjustments; and (3) greater willingness to order specific performance or reformation rather than only monetary damages. Parties should thus document milestone calculations and negotiation history to withstand judicial scrutiny.

Q: What are the key legal and compliance risks of using a VAM in cross-border M&A in 2026?

A: Cross-border VAMs in 2026 present layered legal and compliance risks that demand careful structuring. First, enforceability varies sharply: while common-law jurisdictions like the U.S. and Singapore generally enforce earn-outs as contract terms, civil-law countries may recharacterize them as conditional obligations subject to mandatory company-law rules. In China, VAMs involving outbound investment must comply with foreign exchange controls, the Negative List, and 2025 revisions to the Foreign Investment Law, which increased scrutiny of variable-interest entities. Second, regulatory approvals can derail a VAM: antitrust filings, CFIUS review in the U.S., and the EU's Foreign Subsidies Regulation may treat contingent payments as part of the deal value, potentially triggering stricter thresholds. Third, accounting and tax treatment is inconsistent: IFRS 3 and ASC 805 require contingent consideration to be measured at fair value, but tax authorities in some countries may treat adjustments as taxable income or disguised dividends, creating double taxation. Fourth, data privacy and sanctions rules matter if milestones involve cross-border data flows or restricted parties. Fifth, dispute resolution is complicated—arbitration clauses must be carefully drafted to avoid conflicting outcomes, and enforcement of foreign awards under the New York Convention may be challenged if the VAM is deemed contrary to public policy. Finally, 2026 brings heightened ESG-linked VAMs, where regulators may view sustainability metrics as greenwashing if not independently verified. To mitigate these risks, parties should conduct multi-jurisdictional due diligence, use clear and objective metrics, obtain tax and regulatory pre-clearance where possible, and build in robust dispute-resolution and price-adjustment mechanisms.

Dialogue about

Common scenarios of "Valuation Adjustment Mechanism law"

【Legal Expert】 Good morning, everyone. Today we're discussing the Valuation Adjustment Mechanism, commonly known as VAM. It's a contractual arrangement often used in venture capital investments in China. Can anyone tell me what VAM is?

【Investor】 VAM is essentially a performance-based adjustment to the company's valuation. If the company doesn't meet certain targets, the investor gets compensation, usually in the form of equity or cash.

【Entrepreneur】 From my perspective as a founder, VAM can be a double-edged sword. It helps secure funding, but it also puts a lot of pressure on us to hit aggressive targets.

【Legal Expert】 Indeed. The legal framework around VAM in China has evolved. The Supreme Court's 2012 ruling in the Haifu case set a precedent that VAM agreements between shareholders are generally valid, but those involving the company itself may be subject to restrictions.

【Investor】 That's right. In the Haifu case, the court held that a VAM agreement between the investor and the target company's shareholders was valid, but the part requiring the company to compensate the investor was invalid because it could harm the company's creditors.

【Entrepreneur】 So, if I understand correctly, VAM clauses that require the company to buy back shares or pay cash to investors are risky. They might be unenforceable.

【Legal Expert】 Correct. However, subsequent cases have clarified that if the company's compensation obligation is contingent and doesn't impair its capital or harm creditors, it might be upheld. The key is whether the arrangement violates mandatory provisions of law or public policy.

【Investor】 What about VAM clauses that adjust equity? For example, if the company fails to meet profit targets, the investor gets more shares. Is that enforceable?

【Legal Expert】 Equity adjustment clauses are generally more acceptable because they don't involve direct cash outflow from the company. They are seen as a reallocation of shares among shareholders, which is a matter of private autonomy.

【Entrepreneur】 But equity dilution can still be very damaging for founders. We could lose control of the company.

【Investor】 That's the risk you take when you accept venture capital. VAM is a tool to bridge the valuation gap between what we think the company is worth and what you think it's worth.

【Legal Expert】 There's also the issue of enforceability across different jurisdictions. If the company is incorporated in the Cayman Islands but operates in China, which law applies? Usually, the parties can choose the governing law, but Chinese courts may still apply Chinese law if it affects Chinese public policy.

【Entrepreneur】 So, how can we draft a VAM that is both fair and enforceable? Any best practices?

【Legal Expert】 First, avoid clauses that require the company itself to compensate investors. Instead, place the obligation on the controlling shareholders. Second, set realistic performance targets. Third, include clear definitions and dispute resolution mechanisms.

【Investor】 Also, consider using a combination of equity adjustment and cash compensation from shareholders. That way, if one part is challenged, the other might still hold.

【Entrepreneur】 What about the recent regulatory changes? I heard that the China Securities Regulatory Commission has tightened rules on VAM for IPO applicants.

【Legal Expert】 Yes, for companies seeking an IPO, the CSRC requires that VAM agreements be terminated or cleaned up before the listing. This is to ensure that the company's equity structure is clear and stable. However, some limited exceptions exist for certain types of VAM that don't affect control or cause unfair related-party transactions.

【Investor】 So, if we invest in a company that plans to go public, we need to be prepared to unwind the VAM at the time of IPO. That's a key exit consideration.

【Legal Expert】 Exactly. It's crucial to plan ahead. The VAM should include provisions for termination upon IPO, and the parties should agree on the treatment of any outstanding obligations.

【Entrepreneur】 Thank you. This has been very informative. I think we all agree that VAM is a complex but useful tool, and legal advice is essential to navigate its pitfalls.